Interaction of ambrisentan with clarithromycin and its modulation by polymorphic SLCO1B1

We assessed the effect of cytochrome P450 (CYP) 3A4 and the OATP1B1 inhibitor clarithromycin on ambrisentan steady-state kinetics and its relationship to the SLCO1B1*15 haplotype in healthy volunteers.

Saved in:

Bibliographic Details
Main Authors:	Markert, Christoph (Author) , Hellwig, Regina (Author) , Burhenne, Jürgen (Author) , Hoffmann, Michael Marcus (Author) , Weiß, Johanna (Author) , Mikus, Gerd (Author) , Haefeli, Walter E. (Author)
Format:	Article (Journal)
Language:	English
Published:	9 June 2013
In:	European journal of clinical pharmacology Year: 2013, Volume: 69, Issue: 10, Pages: 1785-1793
ISSN:	1432-1041
DOI:	10.1007/s00228-013-1529-1
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00228-013-1529-1
Author Notes:	Christoph Markert, Regina Hellwig, Jürgen Burhenne, Michael Marcus Hoffmann, Johanna Weiss, Gerd Mikus, Walter E. Haefeli

Description
Summary:	We assessed the effect of cytochrome P450 (CYP) 3A4 and the OATP1B1 inhibitor clarithromycin on ambrisentan steady-state kinetics and its relationship to the SLCO1B1*15 haplotype in healthy volunteers.
Item Description:	Gesehen am 23.06.2021
Physical Description:	Online Resource
ISSN:	1432-1041
DOI:	10.1007/s00228-013-1529-1